Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
Insiders Menu
Roster
Transactions
ZyVersa Therapeutics, Inc.
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
01/26/2023
Guzman Pablo A.
Chief Medical Officer
Grant
Stock Options (right to buy)
100k
$2.11
$211k
01/26/2023
12/16/2022
Wolfe Peter
CFO
Grant
Common Stock
3k
$2.88
$8.6k
12/16/2022
12/12/2022
O'Connor Daniel J.
10% Owner
Other (acquisition)
Warrant (right to buy)
1.8k
$11.50
$20.1k
12/12/2022
12/12/2022
O'Connor Daniel J.
10% Owner
Other (acquisition)
Warrant (right to buy)
177.2k
$11.50
$2M
See Footnote
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Warrant (right to buy)
18.1k
$6.90
$124.6k
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Warrant (right to buy)
11.8k
$11.58
$136.2k
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Stock Options (right to buy)
21.8k
$16.36
$357.3k
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Stock Options (right to buy)
39.7k
$11.58
$459.8k
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Stock Options (right to buy)
9.9k
$5.09
$50.5k
12/12/2022
12/12/2022
Finizio Robert G
Director
Grant
Stock Options (right to buy)
9.9k
$16.36
$162.4k
12/12/2022
12/12/2022
INCON Co., Ltd.
10% Owner
Grant
Common Stock
1.5M
$0.00
$0
12/12/2022
12/12/2022
Finizio Robert G
Director
Grant
Stock Options (right to buy)
19.9k
$16.36
$324.8k
12/12/2022
12/12/2022
Finizio Robert G
Director
Grant
Stock Options (right to buy)
29.8k
$11.58
$344.9k
12/12/2022
12/12/2022
INCON Co., Ltd.
10% Owner
Grant
Warrant (right to buy)
450.7k
$6.90
$3.1M
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Common Stock
448.9k
$0.00
$0
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Series A Convertible Preferred Stock
18
$10.00
$180
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Stock Options (right to buy)
139k
$5.03
$699.1k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Stock Options (right to buy)
168.8k
$5.03
$848.9k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Stock Options (right to buy)
264.8k
$11.58
$3.1M
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Stock Options (right to buy)
126.1k
$16.36
$2.1M
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Stock Options (right to buy)
79.4k
$16.36
$1.3M
12/12/2022
12/12/2022
Wolfe Peter
CFO
Grant
Common Stock
41.6k
$0.00
$0
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Warrant (right to buy)
70.9k
$6.90
$489.1k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Warrant (right to buy)
3k
$11.58
$35k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Warrant (right to buy)
17.9k
$11.58
$207.3k
See footnote
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Warrant (right to buy)
1.8k
$11.50
$20.1k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Common Stock
85.4k
$0.00
$0
See footnote
12/12/2022
12/12/2022
Park Min-Chul
Director
Grant
Stock Options (right to buy)
29.8k
$16.36
$487.2k
12/12/2022
12/12/2022
Park Min-Chul
Director
Grant
Stock Options (right to buy)
9.9k
$16.36
$162.4k
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Common Stock
49.6k
$0.00
$0
See footnote
12/12/2022
12/12/2022
Glover Stephen C.
CEO
Grant
Common Stock
43.8k
$0.00
$0
See footnote
12/12/2022
12/12/2022
LaBella Nicholas A. Jr.
Chief Scientific Officer
Grant
Stock Options (right to buy)
29.8k
$16.36
$487.2k
12/12/2022
12/12/2022
LaBella Nicholas A. Jr.
Chief Scientific Officer
Grant
Warrant (right to buy)
18.1k
$6.90
$124.8k
12/12/2022
12/12/2022
Cashmere Karen A.
Chief Commercial Officer
Grant
Stock Options (right to buy)
21.8k
$16.36
$357.3k
12/12/2022
12/12/2022
Cashmere Karen A.
Chief Commercial Officer
Grant
Stock Options (right to buy)
29.8k
$11.58
$344.9k
12/12/2022
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy